CHRISTINA BURGESS: Open Payments
NPI 1477273910 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,100 in 119 payments from 19 companies in 2025. Trend: 2023 $1,592 · 2024 $2,258 · 2025 $2,100
Food & beverage: $2,089Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $835 |
| Madrigal Pharmaceuticals | 9 | $209 |
| Ardelyx, Inc. | 14 | $169 |
| Janssen Biotech, Inc. | 8 | $161 |
| Ipsen Biopharmaceuticals, Inc | 5 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 5 | $85 |
| Gilead Sciences, Inc. | 4 | $81 |
| Organon LLC | 3 | $69 |
| PFIZER INC. | 3 | $63 |
Products named: RINVOQ, SKYRIZI, REZDIFFRA, TREMFYA, IBSRELA, IQIRVO, XIFAXAN, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
